{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:53:01Z","timestamp":1761155581096},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,9,25]]},"DOI":"10.1212\/wnl.57.6.972","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:56:15Z","timestamp":1336917375000},"page":"972-978","source":"Crossref","is-referenced-by-count":66,"title":["Assessment of health economics in Alzheimer\u2019s disease (AHEAD)"],"prefix":"10.1212","volume":"57","author":[{"given":"D.","family":"Getsios","sequence":"first","affiliation":[{"name":"From Caro Research (D. Gestios, G. Caro, and K. Ishak), Montreal, Quebec, Canada; Caro Research Institute (J.J. Caro), Concord, MA; and Division of General Internal Medicine, McGill University (J.J. Caro), Montreal, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Caro","sequence":"additional","affiliation":[{"name":"From Caro Research (D. Gestios, G. Caro, and K. Ishak), Montreal, Quebec, Canada; Caro Research Institute (J.J. Caro), Concord, MA; and Division of General Internal Medicine, McGill University (J.J. Caro), Montreal, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Caro","sequence":"additional","affiliation":[{"name":"From Caro Research (D. Gestios, G. Caro, and K. Ishak), Montreal, Quebec, Canada; Caro Research Institute (J.J. Caro), Concord, MA; and Division of General Internal Medicine, McGill University (J.J. Caro), Montreal, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ishak","sequence":"additional","affiliation":[{"name":"From Caro Research (D. Gestios, G. Caro, and K. Ishak), Montreal, Quebec, Canada; Caro Research Institute (J.J. Caro), Concord, MA; and Division of General Internal Medicine, McGill University (J.J. Caro), Montreal, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the AHEAD Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"S1","volume":"160","year":"1999","unstructured":"Patterson CJS, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ . 1999; 160: S1\u2013S15.","journal-title":"CMAJ"},{"key":"e_1_3_2_3_2","first-page":"899","volume":"150","year":"1994","unstructured":"Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ . 1994; 150: 899\u2013913.","journal-title":"CMAJ"},{"key":"e_1_3_2_4_2","first-page":"1457","volume":"151","year":"1994","unstructured":"Ostbye T, Crosse E. Net economic costs of dementia in Canada. CMAJ . 1994; 151: 1457\u20131464.","journal-title":"CMAJ"},{"key":"e_1_3_2_5_2","first-page":"457","volume":"159","year":"1998","unstructured":"Hux MJ, O\u2019Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation between disease severity and costs of caring. CMAJ . 1998; 159: 457\u2013465.","journal-title":"CMAJ"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2261"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7252.1"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2269"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1356"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051228"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Caro JJ Getsios D Migliaccio\u2013Walle K Raggio G Ward A for the AHEAD Study Group. Assessment of health economics in Alzheimer\u2019s disease (AHEAD) based on need for full-time care. Neurology 2001;57:964\u2013971.","DOI":"10.1212\/WNL.57.6.964"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540150055031"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_2_14_2","first-page":"806","volume":"227","year":"1997","unstructured":"Stern Y, Tang MX, Albert M, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA . 1997; 227: 806\u2013812.","journal-title":"JAMA"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.2.179"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1511"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199901000-00005"},{"key":"e_1_3_2_18_2","unstructured":"Jacobs P Bachynsky J Hall E. A manual of standard costs for pharmaco-economic studies in Canada: feasibility study. Ottawa: Canadian Coordinating Office for Health Technology Assessment October 1995."},{"key":"e_1_3_2_19_2","unstructured":"University of Ottawa Faculty of Medicine. The Canadian Study of Health and Aging home page. Available at: http:\/\/www.uottawa.ca\/academic\/med\/epid\/csha.html. Accessed August 11 2000."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1136"},{"key":"e_1_3_2_21_2","unstructured":"Wolfson C Moride Y Perrault A Vida S. A study of the efficacy effectiveness and economic impact of tacrine in Alzheimer\u2019s disease. Ottawa: Canadian Coordinating Office for Health Technology Assessment June 1997."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1607::AID-SIM449>3.0.CO;2-O"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199903000-00002"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199911050-00004"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051229"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90201-5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199710)12:10<978::AID-GPS659>3.0.CO;2-1"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Busschbach JV Brouwer WBF van der Donk A Passcheir J Rutten FFH. An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer\u2019s disease. Pharmacoeconomics 1998:13:21\u201334.","DOI":"10.2165\/00019053-199813010-00003"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb02572.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)89012-8"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.57.6.972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T18:02:40Z","timestamp":1711648960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.6.972"}},"subtitle":["Galantamine treatment in Canada"],"short-title":[],"issued":{"date-parts":[[2001,9,25]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,9,25]]}},"alternative-id":["10.1212\/WNL.57.6.972"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.6.972","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"type":"print","value":"0028-3878"},{"type":"electronic","value":"1526-632X"}],"subject":[],"published":{"date-parts":[[2001,9,25]]}}}